Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2014
04/30/2014CN103054817B Vidarabine monophosphate pharmaceutical composition and preparation method thereof
04/30/2014CN102973489B Florfenicol solid dispersoid and preparation method thereof
04/30/2014CN102965345B Porcine parvovirus, vaccine composition and application thereof
04/30/2014CN102952185B Novel defensin pdBD, and gene and application thereof
04/30/2014CN102824566B Herbal composition for preventing and curing swine fever
04/30/2014CN102805731B Posaconazole dry suspension and preparation method thereof
04/30/2014CN102784219B Compound pure Chinese medicine composition for treating bovine ephemeral fever and preparation method of same
04/30/2014CN102784136B Preparation process of compound florfenicol injection for livestock
04/30/2014CN102732544B A method for expelling a bacillus anthracis virulence large plasmid pXO1
04/30/2014CN102716115B Pharmaceutical composition
04/30/2014CN102614174B Dry suspension containing amoxicillin and potassium clavulanate
04/30/2014CN102614118B Preparation method for epirubicin hydrochloride preparation for injection and preparation
04/30/2014CN102596219B Novel bacteriophage and antibacterial composition comprising the same
04/30/2014CN102579283B Mineral massage bath salt and production method thereof
04/30/2014CN102552560B Compound combination medicament for effectively treating hand-foot-and-mouth disease
04/30/2014CN102552557B Traditional Chinese medicine composition for treating herpes zoster and sequelae of herpes zoster as well as preparation and preparation method of traditional Chinese medicine composition
04/30/2014CN102552492B Traditional Chinese medicinal composition for treating herpes zoster and preparation method thereof
04/30/2014CN102443060B Anti-HPV (human papilloma virus) antibody and preparation method and application thereof
04/30/2014CN102272081B Tetrahydronaphthalen-2-ol derivatives
04/30/2014CN101775017B Macrocyclic hepatitis c serine protease inhibitors
04/30/2014CN101724075B Remodeling and glycoconjugation of peptides
04/30/2014CN101712707B Three crystal-form substances of roxithromycin, preparation method, pharmaceutical composition and application thereof
04/30/2014CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/29/2014US8710229 Hepatitis C virus inhibitors
04/29/2014US8710198 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
04/29/2014US8710073 Anti-infective derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment
04/29/2014US8710030 Phosphonate compounds
04/29/2014US8709498 Method of stimulating tissue healing
04/29/2014US8709496 Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
04/29/2014US8709443 Reovirus for the treatment of cellular proliferative disorders
04/29/2014US8709442 Recombinant negative strand virus RNA expression systems and vaccines
04/29/2014US8709428 Antibodies to Clostridium difficile toxins
04/29/2014US8709427 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form
04/29/2014US8709425 Antibodies to non-functional P2X7 receptor
04/29/2014US8709385 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
04/29/2014CA2777018C Novel method for preparing entecavir and intermediate used therein
04/29/2014CA2775393C Topical non-aqueous pharmaceutical formulations
04/29/2014CA2704778C Formulations for enhanced bioavailability of orally administered polar agents
04/29/2014CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
04/29/2014CA2408571C Mammalian receptor proteins; related reagents and methods
04/29/2014CA2400485C Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
04/29/2014CA2232048C Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins
04/24/2014WO2014063168A1 Heterocycle-bisamide inhibitors of scavenger receptor bl
04/24/2014WO2014063167A1 Thiazole-based inhibitors of scavenger receptor bi
04/24/2014WO2014063059A1 Broadly-neutralizing anti-hiv antibodies
04/24/2014WO2014063019A1 Dinucleotide compounds for hcv infection
04/24/2014WO2014062596A1 2'-methyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
04/24/2014WO2014062347A1 Antibacterial monomers, antibacterial resins and dental composites comprising the antibacterial resins
04/24/2014WO2014062196A1 Hepatitis c virus inhibitors
04/24/2014WO2014061825A1 Treatment of viral and infectious diseases using an inhibitor of cbp/catenin
04/24/2014WO2014061752A1 Compound; tautomer and geometric isomer thereof; salt of said compound, tautomer, or geometric isomer; method for manufacturing said compound, tautomer, isomer, or salt; antimicrobial agent; and anti-infective drug
04/24/2014WO2014061693A1 Novel non-aromatic carbocyclic or non-aromatic heterocyclic derivative
04/24/2014WO2014060588A1 2,3-dihydroquinazolin-4(1 h)-one derivatives for use in the treatment of viral infections
04/24/2014WO2014060581A1 Use of hydroxytirosol and derivatives thereof as quorum quenchers
04/24/2014WO2014060493A2 N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
04/24/2014WO2014060432A1 Pyrrolotriazinone derivatives as pi3k inhibitors
04/24/2014WO2014060431A1 Pyrrolotriazinone derivatives as pi3k inhibitors
04/24/2014WO2014060411A1 Rsv antiviral compounds
04/24/2014WO2014060138A1 Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia
04/24/2014WO2014059902A1 2'-disubstituted substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
04/24/2014WO2014059901A1 2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
04/24/2014WO2014059880A1 Method for preparation of pomegranate-peel polyphenol gel used to treat gynecological inflammation
04/24/2014WO2014059489A1 Improved human herpesvirus immunotherapy
04/24/2014WO2014036502A3 Tetracycline compounds
04/24/2014WO2014036443A3 Heterocyclyl carboxamides for treating viral diseases
04/24/2014US20140112904 Method for enhancing the cleavage activity of i-crei derived meganucleases
04/23/2014EP2722386A1 Crushed cells and composition thereof
04/23/2014EP2722322A2 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
04/23/2014EP2722053A1 Antibacterial agent for treating infectious diseases of bacterial origin
04/23/2014EP2722047A1 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections
04/23/2014EP2722042A2 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
04/23/2014EP2721071A1 Tem8 antibodies, conjugates thereof, and their use
04/23/2014EP2721053A1 Hepatitis c virus inhibitors
04/23/2014EP2721026A1 Phosphate esters of gyrase and topoisomerase inhibitors
04/23/2014EP2721023A1 Metalloenzyme inhibitor compounds
04/23/2014EP2721014A2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
04/23/2014EP2721013A1 Process for the preparation of a chiral compound
04/23/2014EP2720754A2 Leukotoxin e/d as a new anti-inflammatory agent and microbicide
04/23/2014EP2720706A2 Group a streptococcus multivalent vaccine
04/23/2014CN103748220A Bacteriocin derived from lactobacillus rhamnosus
04/23/2014CN103748103A Methods for preparation of glycosphingolipids and uses thereof
04/23/2014CN103748098A Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
04/23/2014CN103748081A Quinazoline derivatives for the treatment of viral infections and further diseases
04/23/2014CN103748060A 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
04/23/2014CN103747799A Cytotoxic t cell inducer
04/23/2014CN103747784A Prophylactic agent and/or therapeutic agent for sepsis
04/23/2014CN103740759A Recombinant turkey herpesvirus of expressing H5N1subtype avian influenza virus HA gene
04/23/2014CN103740758A Recombinant baculovirus vector, virus like particle, preparation method and use
04/23/2014CN103740743A Recombined rhabdovirus for expressing porcine bocavirus VP2 protein and application thereof
04/23/2014CN103740741A HPV18 E and E7 fusion gene mutant as well as related biological material and coding protein thereof
04/23/2014CN103740736A Chemically synthesized gene segment of gE (glycoprotein E) extracellular domain of HSV2 (herpes simplex virus) as well as expression method and application thereof
04/23/2014CN103740735A Gene segment in extracellular region of chemosynthetic HSV2 (Herpes Simplex Virus Type 2) virus gC glycoprotein as well as expression and application of gene segment
04/23/2014CN103740658A Viperin, and preparation and application of viperin
04/23/2014CN103740656A Method for purifying recombined hansenula polymorpha hepatitis E virus-like particles and application
04/23/2014CN103740655A H5N1 avian influenza virus-like particle, application and preparation method of virus-like particle, and vaccine
04/23/2014CN103740654A Cold adaptation strain of influenza B virus Vero cell and application thereof
04/23/2014CN103740653A Porcine transmissible gastroenteritis virus and application thereof
04/23/2014CN103740650A Monoclonal antibody BTV16-3G10 resistant to bluetongue virus serum 16 type VP2 protein, B-cell epitope polypeptide identified by monoclonal antibody BTV16-3G10, and applications of monoclonal antibody BTV16-3G10
04/23/2014CN103740649A Monoclonal antibody BTV16-2B4 resistant to bluetongue virus serum 16 type VP2 protein, B-cell epitope identified by monoclonal antibody BTV16-2B4, and applications of monoclonal antibody BTV16-2B4
04/23/2014CN103740632A Recombinant Escherichia coli and application thereof in preparation of anti-O157:H7 N-glycoprotein vaccine
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 1798